C5s 5th

EU Pharma Regulatory Law

Minimising Risks by Ensuring Compliance with New Regulatory Developments

Tuesday, September 25 to Wednesday, September 26, 2012
TBC, Brussels

Managers, directors and in house counsel from the pharma, biotech and healthcare industries having responsibility for:

• Regulatory affairs
• Drug development and approval processes
• Pharmaceutical law and regulation
• Licensing and M&A
• Medical affairs

Lawyers, patent attorneys and consultants to the pharma, biotech and healthcare industries whose practices focus on:

• Pharmaceutical law and regulation
• Regulatory compliance
• Patent litigation
• Licensing and M&A

Regulatory professionals from national and international regulatory bodies

Clinical Research Organisations (CROs) that conduct clinical research for the pharma and biotech industries

Investment bankers and venture capitalists whose clients and portfolio companies operate in the pharma and biotech industries

TO REQUEST A BROCHURE BE SENT AS SOON AS IT IS PRODUCED, PLEASE SEND AN EMAIL TO TOBY HARTLEY (T.HARTLEY@C5-ONLINE.COM) QUOTING 'PRLABR' IN THE SUBJECT LINE.